Lung Cancer
3 articles

Cosmos & Physics
Study on Morning Cancer Therapy Effectiveness Retracted Due to Flaws
A paper in Nature Medicine , which suggested non-small cell lung cancer patients could benefit from morning immunotherapy, has been formally retracted following a four-month investigation, according t
Dr. Evelyn Reed·June 25, 2026

Cosmos & Physics
New blood test finds 14 proteins signaling lung cancer risk
A novel blood test can now identify a signature of 14 proteins, predicting an individual's lung cancer risk more than five years before diagnosis, according to Inside Precision Medicine .
Dr. Evelyn Reed·June 9, 2026

Computational Science & Software
Pfizer Shares Updated Lung Cancer Bispecifics Data at ASCO
At the ASCO Annual Meeting, updated Phase 2 data for Pfizer's bispecific antibody PF-08634404 demonstrated activity as monotherapy in first-line PD-L1-expressing non-small cell lung cancer.
Yasmin Haddad·May 31, 2026